Pharmacovigilance Specialist at Enterprise
High Conscientiousness and Openness to detect safety signals, manage PSURs, and keep the PV system regulatory compliant.
In enterprise pharma, multi-market regulatory complexity is the norm
10-15 year development cycles require genuine long-term vision
Pharmacovigilance and patient safety are non-delegable responsibilities
Ideal OCEAN+ Profile
At enterprise companies (201-1000 employees), analytical ability to detect emerging signals in safety data, interpret trends, and propose complex risk-benefit assessments
At enterprise companies (201-1000 employees), rigor in case follow-up, generating periodic reports, keeping SOPs current, and meeting reporting obligations to agencies
At enterprise companies (201-1000 employees), presenting safety findings to internal committees and regulatory agencies; communicating PV system updates across the organization
At enterprise companies (201-1000 employees), collaboration with medical affairs, regulatory, clinical, and legal for comprehensive management of product safety obligations
At enterprise companies (201-1000 employees), managing stress from critical safety signals that require fast regulatory response and decisions that affect product availability
At enterprise companies (201-1000 employees), the pharmacovigilance specialist sustains the periodic reporting cycle (PSUR/PBRER), signal management, and risk-evaluation SOPs; process adherence is what makes the safety dossier defensible under inspection
Strengths and Red Flags
Strengths
- Detection and evaluation of emerging safety signals using robust statistical methodologies
- Management of PSURs, PADERs, and benefit-risk reports with high documentation quality
- Managing product portfolios across multiple development and commercialization phases
- Robust regulatory compliance with FDA, EMA, and local health authorities
Red Flags
- Mechanical case processing without a signal-detection mindset, turning PV into a bureaucratic process
- Missed reporting deadlines that expose the company to regulatory action
- Paralysis in the face of complex multi-product, multi-phase portfolios
- Internal bureaucracy that delays go/no-go pipeline decisions
Interview Questions
Have you ever detected an emerging safety signal? Describe what data alerted you, what evaluation methodology you used, and what regulatory action followed.
Evaluates: Analytical Openness and rigor in signal detection and evaluation
How many PSURs or PADERs have you prepared? Describe your process for generating the Benefit-Risk Summary and the most common errors you avoid.
Evaluates: Conscientiousness and technical mastery of periodic safety reporting
How did you manage a multi-product portfolio across different development phases?
Evaluates: Systemic vision and prioritization capacity at scale
How did you coordinate a multi-market regulatory registration process?
Evaluates: Conscientiousness and coordination in highly complex environments
More about Pharmacovigilance Specialist
Career path, personality archetypes and similar roles in the full profile.
This Role in Other Contexts
Pharmacovigilance Specialist — base profile with no company context
View profile → Startup (1-50 employees)In pharma startups, time to regulatory approval defines survival
View profile → SMB (51-200 employees)In SMB pharma, quality and compliance are the license to operate
View profile → Global (1001+ employees)Global pharma means registrations in dozens of markets with different requirements
View profile →Does your next Pharmacovigilance Specialist at Enterprise (201-1000 employees) match this profile?
Map anyone's OCEAN+ profile with the Talent Diagnostic: free, no signup, 10 minutes.
20 statements · 10 minutes · no card